Clinical Trials Directory

Trials / Completed

CompletedNCT05702957

Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome

Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome: Randomised Control Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
220 (actual)
Sponsor
Services Institute of Medical Sciences, Pakistan · Other Government
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

It was randomised controlled study to compare the efficacy of clomiphene and letrozole in polycystic ovarian syndrome(PCOS) women with infertility.The aim was to select more appropriate treatment for ovulation induction in PCOS women.

Detailed description

The prevalence of infertility due to polycystic ovarian syndrome in Pakistan is 21.9%.It leads to an ovulation which results in infertility.The objective of this study was to compare the efficacy of letrozole vs clomiphene citrate for ovulation induction in PCOS women.Methods.It was a randomised controlled trial conducted in department of gynaecology and obstetrics ,Services Hospital Lahore from 2016-2019. Total 230 patients were included in study, they were divided in two groups, out of which 220 patients were analysed. .Group-A patients were given clomiphene citrate 50-150mg per day for 5 days starting from 2nd day of menses and group B patients were given letrozole 2.5-7.5mg per day for 5 days. Transvaginal ultrasound monitoring done from day 10-12 of menstrual cycle to measure follicle number and size.When follicle achieved a diameter of 18-20mm, then Inj HCG(human chorionic gonadotropin)10,000 IU intramuscular was given. Ovulation was confirmed by day 21 S.progesterone. When patient conceived, they were followed up till delivery.

Conditions

Interventions

TypeNameDescription
DRUGletrozole 2.5mg-7.5mgTab letrozole 2.5 mg-7.5mg per day for 5 days started from 2nd day of menses.
DRUGClomiphene Citrate 50mg-150mgTab clomiphene citrate 50-150mg per day for 5 days started from 2nd day of menses.

Timeline

Start date
2016-09-01
Primary completion
2019-10-01
Completion
2019-12-01
First posted
2023-01-27
Last updated
2023-01-27

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05702957. Inclusion in this directory is not an endorsement.